Reply to fedson

Journal of Infectious Diseases

Volumn 209, Issue 8, 2014, Pages 1301-1302

  Van Wormer, Jeffrey J ^a   Bateman, Allen C ^b,c   Irving, Stephanie A ^d   Kieke, Burney A ^a   Shay, David K ^e   Belongia, Edward A ^a  

^a MARSHFIELD CLINIC   (United States)

^b Centre for Infectious Disease Research   (Zambia)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; METFORMIN;

ACUTE RESPIRATORY TRACT DISEASE; ANALYTIC METHOD; DISEASE SEVERITY; DRUG EFFICACY; FALSE NEGATIVE RESULT; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LETTER; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TEST NEGATIVE DESIGN; TREATMENT OUTCOME;

FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANDEMICS;

EID: 84897406369     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit810     Document Type: Letter

References (10)

1. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, national health and nutrition examination surveys, 2003-2010. J Infect Dis 2013; 208: 385-93.
2. Burchell AN, Tellier PP, Hanley J, Coutlée F, Franco EL. Influence of partner's infection status on prevalent human papillomavirus among persons with a new sex partner. Sex Transm Dis 2010; 37:34-40.
3. Centers for Disease Control and Prevention. Sexual experience and contraceptive use among female teens-United States, 1995, 2002, and 2006-2010. MMWR 2012; 61:297-301.
4. Centers for Disease Control and Prevention (CDC). Trends in HIV-related risk behaviors among high school students-United States, 1991-2011. MMWR 2012; 61:556-60.
5. Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics 2013; 131: 548-58.
6. Harper DM, Groner JA, Griffith RS, Harper WH. RE: Annual report to the nation on the status of cancer, 1975-2009, featuring the 7. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13-17 years-United States. 2011.MMWR 2012; 34:671-7.
7. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-9.
8. Dobson SR, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial. JAMA 2013; 309:1793-802.
9. Harper DM, Vierthaler SL, Santee JA. Review of gardasil. J Vaccines Vaccin 2010; 1. doi:pii: 1000107.
10. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30(Suppl 5): F12-23.